Ngenla 60 mg/1.2 mL (50 mg/mL) prefilled pen Images
Generic Name: somatrogon
This medication has been identified as Ngenla 60 mg/1.2 mL (50 mg/mL) prefilled pen. It is supplied by Pfizer Inc.
Ngenla is used in the treatment of Pediatric Growth Hormone Deficiency and belongs to the drug class growth hormones. Ngenla 60 mg/1.2 mL (50 mg/mL) prefilled pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Ngenla
- Generic Name
- somatrogon
- Strength
- 60 mg/1.2 mL (50 mg/mL) prefilled pen
- Availability
- Prescription only
- Drug Class
- Growth hormones
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0520
See also:
Humatrope
Humatrope injection (somatropin) is a human growth hormone used to treat growth failure in children ...
Sogroya
Sogroya information from Drugs.com, includes Sogroya side effects, interactions and indications.
Skytrofa
Skytrofa injection is a once-weekly, slow-release human growth hormone (lonapegsomatropin) ...
Genotropin
Genotropin is a human growth hormone used to treat growth failure in children and adults who lack ...
Norditropin
Norditropin is used to treat growth hormone deficiency (GHD) in adults and children and other ...
Omnitrope
Omnitrope (somatropin) is a form of human growth hormone used to treat adults and children with ...
Norditropin FlexPro
Norditropin FlexPro is used for adult human growth hormone deficiency, idiopathic short stature ...
Nutropin
Nutropin is used for adult human growth hormone deficiency, growth retardation, chronic renal ...
Nutropin AQ
Nutropin AQ (somatropin) is an injectable preparation that may be used to treat children with ...
More about Ngenla (somatrogon)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.